EDGAR·FLOW

ORAMED PHARMACEUTICALS INC. — Form 8-K

Filed November 19, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 8/100
What the filing says
Oramed Pharmaceuticals filed an 8-K on November 19, 2026, reporting a Period of Report date of November 5, 2026. The filing contains only Item 8.01 (Other Events) with no specific material transaction, deal, financing, or operational change disclosed in the available filing documents. The actual substance of the 'Other Events' disclosure is not provided in the filing index text.
Why this rating

No material transaction, counterparty, amount, or business change specified. Routine disclosure filing. Without substantive content detail, cannot assess real impact.

Extracted items
View original filing on SEC.gov ↗ ORMP · stock on Yahoo Finance ↗

See more from November 19, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.